Back

Notification report


Full notification file


General information

Notification Number
B/DE/14/2247

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
20/10/2014

Title of the Project
Phase I clinical testing of experimental Ebola Vaccine VSVΔG-ZEBOV

Proposed period of release:
01/01/2014 to 31/12/2014

Name of the Institute(s) or Company(ies)
Universitätsklinikum Hamburg-Eppendorf, ;


3. Is the same GMO release planned elsewhere in the Community?
Not known

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Identity of the GMO (genus and species)
VSVΔG-ZEBOV, derivative of VSV Indiana, expressing instead of VSV-G the Zaire Ebola transmembrane glycoprotein (Garbutt et al., 2004)


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
VSVVesiculo virusVesicular stomatitis virusIndiana serotypeGI:9627229, GenBank Locus NC_001560

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
11/06/2014 00:00:00
Remarks: